An exploratory randomised controlled trial using short messaging service to facilitate insulin administration in young adults with type 1 diabetes

a Institute of Psychological Sciences , University of Leeds , Leeds , UK.
Psychology Health and Medicine (Impact Factor: 1.26). 05/2012; 18(2). DOI: 10.1080/13548506.2012.689841
Source: PubMed


This exploratory randomised controlled trial examined the effectiveness of a novel short messaging service intervention underpinned by the theory of planned behaviour (TPB) in improving insulin administration in young adults with type 1 diabetes and the role of moderating variables. Those in the intervention condition (N = 8) received one daily text message underpinned by TPB constructs: Attitudes, subjective norms, perceived behavioural control and intention. Those in the control condition (N = 10) received weekly general health messages. Self-reported insulin administration was the main outcome measure; conscientiousness and consideration of future consequences (CFC) were measured as potential moderators. Analyses of covariance revealed no main effects of condition for morning and afternoon injections but a marginally significant effect for evening injections (p = .08). This main effect was qualified by significant interactions of condition with conscientiousness (p = .001), CFC (p = .007) and a three-way interaction among condition, conscientiousness and CFC (p = .009). Exploration of the interactions indicated the intervention significantly improved evening injection rates only in the low conscientiousness and low CFC groups. This effect was particularly strong among those low in both conscientiousness and CFC. Further investigation is warranted, using more objective measures of insulin adherence in a larger sample.

Download full-text


Available from: Gemma Louch, Jul 22, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Internetgängige Mobiltelefone, sog. Smartphones, erlauben es den Nutzern, über das Internet Programme („Apps“) herunterzuladen und diese überall und jederzeit bei der Bewältigung unterschiedlicher Aufgaben einzusetzen. Dabei ergeben sich neue Möglichkeiten, Hypertoniepatienten und ihren Erfordernissen besser gerecht zu werden. Insbesondere im Hinblick auf Therapieadhärenz, Blutdruckkontrolle und lebensstiländernde Maßnahmen haben Mobilapplikationen und kombinierte Blutdruckmessgeräte das Potenzial, die Therapie zu verbessern. Momentan interessieren sich besonders jüngere Nutzer für eine solche Technologie. In Zukunft ist davon auszugehen, dass sich diese auch bei älteren und multimorbideren Nutzern durchsetzen wird. Hier mögen Kosten sowie ein Soft- und Hardware-Angebot (z. B. Tablet-PCs), das sich an den speziellen Bedürfnissen einer älteren Nutzergruppe orientiert, entscheidende Faktoren sein.
    Herz 11/2012; 37(7). DOI:10.1007/s00059-012-3685-y · 0.69 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: to identify salient behavioral, normative, control and self-efficacy beliefs related to the behavior of adherence to oral antidiabetic agents, using the Theory of Planned Behavior. Method: cross-sectional, exploratory study with 17 diabetic patients in chronic use of oral antidiabetic medication and in outpatient follow-up. Individual interviews were recorded, transcribed and content-analyzed using pre-established categories. Results: behavioral beliefs concerning advantages and disadvantages of adhering to medication emerged, such as the possibility of avoiding complications from diabetes, preventing or delaying the use of insulin, and a perception of side effects. The children of patients and physicians are seen as important social references who influence medication adherence. The factors that facilitate adherence include access to free-of-cost medication and taking medications associated with temporal markers. On the other hand, a complex therapeutic regimen was considered a factor that hinders adherence. Understanding how to use medication and forgetfulness impact the perception of patients regarding their ability to adhere to oral antidiabetic agents. Conclusion: medication adherence is a complex behavior permeated by behavioral, normative, control and self-efficacy beliefs that should be taken into account when assessing determinants of behavior.
    Revista Latino-Americana de Enfermagem 07/2014; 22(4):529-537. DOI:10.1590/0104-1169.3578.2448 · 0.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Insulin is used in all subjects with Type 1 diabetes, and when Type 2 diabetes is not controlled by oral anti-diabetic medicines, insulin is also used in Type 2 diabetes. However, despite this use, there is still increased mortality and morbidity in subjects with diabetes, compared to subjects without diabetes. One of the factors, which may be involved in this increased mortality and morbidity in subjects with diabetes, is nonadherence to insulin. Nonadherence rates to insulin are in the range20-38%, and many factors contribute to the nonadherence. The major aim of the review was to determine whether interventions to improve adherence to insulin do actually improve adherence to insulin. Most studies have shown that adherence to insulin was improved by changing from the vial-and-syringe approach to prefilled insulin pens, but not all studies have shown that this translated into better glycemic control and clinical outcomes. The results of studies using automatic telephone messages to improve adherence to insulin to date are inconclusive. There is limited and variable evidence that an intervention by a nurse/educator, which discusses adherence to medicines, does improve adherence to insulin. In contrast, there is little or no evidence that an extra intervention by a doctor or an intervention by a pharmacist, which discusses adherence to insulin, does actually improve the measured adherence to insulin. In conclusion, rather than assuming that an intervention by a health professional discussing adherence to insulin actually improves adherence to insulin, long-term studies investigating this are required.
    Journal of Diabetes 09/2014; 7(3). DOI:10.1111/1753-0407.12212 · 1.93 Impact Factor
Show more